Earnings Preview: Agios Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Agios Pharmaceuticals (NASDAQ:AGIO) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $-1.65. Historical data shows variable stock price reactions to past earnings reports, with a 7.1% increase following the last quarter's beat. Shares are currently trading at $25.15, reflecting a 4.61% decline over the past year. Investors are keen on both the earnings outcome and the company's future guidance.
February 14, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Agios Pharmaceuticals is expected to report an EPS of $-1.65 for the upcoming quarter. Historical performance shows a mixed reaction to earnings reports, with a notable 7.1% stock price increase after last quarter's beat. Currently, shares are trading at $25.15, down 4.61% over the last year.
The expected EPS of $-1.65 and historical earnings performance suggest a cautious outlook for AGIO's stock price in the short term. While past earnings beats have led to positive stock price movements, the overall yearly decline indicates underlying challenges. The company's future guidance will be crucial in determining short-term stock price direction.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100